Lightship Inc., a leading provider of community-based, decentralized clinical trial services, is pleased to announce the appointment of Michael Shipton as Chief Commercial Officer (CCO). With a proven track record of driving growth and innovation in the life sciences and technology sectors, Shipton will play a key role in reshaping Lightship’s go-to-market strategy and strengthening its ability to meet the growing complexity of representative clinical trials.
“Michael’s appointment comes at a critical juncture in Lightship’s growth,” said David MacMurchy, CEO of Lightship.
Shipton brings over 30 years of experience in designing and executing high-impact business solutions, with expertise across sales management and operations, marketing, strategic pricing and partnerships, finance, global operations, and customer engagement. As Lightship enters an exciting new phase of growth, his leadership will be essential in expanding the company’s service offerings and driving strategic business development efforts that will enable Lightship to meet the evolving needs of its clients.
Health Technology Insights: Digital Health Market to reach USD 40.28 billion in 2030
“Michael’s appointment comes at a critical juncture in Lightship’s growth,” said David MacMurchy, CEO of Lightship. “His extensive experience working in both the CRO and site spaces, combined with his ability to solve complex client challenges, makes him the ideal leader to strengthen our market positioning. Michael’s strategic vision, proven ability to drive business growth, and commitment to patient-centered solutions will be instrumental in helping us expand our reach to more clients—and ultimately more patients—enhancing our impact across the industry.”
Health Technology Insights: Agricultural Biologicals Market to Reach $25.2Billion by 2030
Shipton has held senior leadership positions at some of the most recognized names in the industry, including Profound Research, Science 37, Syneos Health, and Quintiles (now IQVIA), where he led significant go-to-market transformations, drove sales growth, and oversaw cross-functional teams to achieve commercial excellence. His proven track record and passion for improving health outcomes will be critical to driving Lightship’s mission forward with even greater impact.
“I have always believed in the transformative power of clinical trials to improve health outcomes, and I’m excited to join Lightship during this pivotal period of growth,” said Shipton. “I look forward to collaborating with the team to advance Lightship’s mission, reach more patients, and develop solutions that address the complexities facing clinical trials today. Together, we can continue to make trials more accessible, inclusive, and impactful for individuals and communities everywhere.”
Health Technology Insights: Abbott Gets CE Mark for Volt Pulsed Field Ablation System
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
